IL272124A - Treatment of non-inflammatory lesions - Google Patents
Treatment of non-inflammatory lesionsInfo
- Publication number
- IL272124A IL272124A IL272124A IL27212420A IL272124A IL 272124 A IL272124 A IL 272124A IL 272124 A IL272124 A IL 272124A IL 27212420 A IL27212420 A IL 27212420A IL 272124 A IL272124 A IL 272124A
- Authority
- IL
- Israel
- Prior art keywords
- treatment
- inflammatory lesions
- lesions
- inflammatory
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762535572P | 2017-07-21 | 2017-07-21 | |
| PCT/IB2018/000938 WO2019016609A1 (en) | 2017-07-21 | 2018-07-20 | TREATMENT OF NON-INFLAMMATORY LESIONS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL272124A true IL272124A (en) | 2020-03-31 |
Family
ID=63713912
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL272124A IL272124A (en) | 2017-07-21 | 2020-01-19 | Treatment of non-inflammatory lesions |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20200222432A1 (https=) |
| EP (1) | EP3654988B1 (https=) |
| JP (1) | JP2020527607A (https=) |
| KR (1) | KR102662461B1 (https=) |
| CN (1) | CN111343991A (https=) |
| AU (1) | AU2018303807B2 (https=) |
| BR (1) | BR112020000968A2 (https=) |
| CA (1) | CA3070663A1 (https=) |
| ES (1) | ES2962380T3 (https=) |
| IL (1) | IL272124A (https=) |
| MA (1) | MA49641A (https=) |
| MX (1) | MX2020000816A (https=) |
| WO (1) | WO2019016609A1 (https=) |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2990331A (en) | 1956-11-23 | 1961-06-27 | Pfizer & Co C | Stable solutions of salts of tetracyclines for parenteral administration |
| US2980584A (en) | 1957-10-29 | 1961-04-18 | Pfizer & Co C | Parenteral magnesium oxytetracycline acetic or lactic acid carboxamide vehicle preparation |
| US3062717A (en) | 1958-12-11 | 1962-11-06 | Pfizer & Co C | Intramuscular calcium tetracycline acetic or lactic acid carboxamide vehicle preparation |
| US3165531A (en) | 1962-03-08 | 1965-01-12 | Pfizer & Co C | 13-substituted-6-deoxytetracyclines and process utilizing the same |
| US3454697A (en) | 1965-06-08 | 1969-07-08 | American Cyanamid Co | Tetracycline antibiotic compositions for oral use |
| NL6607516A (https=) | 1966-05-31 | 1967-12-01 | ||
| DE1767891C3 (de) | 1968-06-28 | 1980-10-30 | Pfizer | Verfahren zur Herstellung von wäßrigen arzneilichen Lösungen für die parenterale, perorale und lokale Anwendung mit einem Gehalt an einem Tetracyclinderivat |
| US3957980A (en) | 1972-10-26 | 1976-05-18 | Pfizer Inc. | Doxycycline parenteral compositions |
| DE2442829A1 (de) | 1974-09-06 | 1976-03-18 | Merck Patent Gmbh | Tetracyclische verbindungen und verfahren zu ihrer herstellung |
| US4018889A (en) | 1976-01-02 | 1977-04-19 | Pfizer Inc. | Oxytetracycline compositions |
| US4126680A (en) | 1977-04-27 | 1978-11-21 | Pfizer Inc. | Tetracycline antibiotic compositions |
| EP1383508B1 (en) * | 2001-04-05 | 2006-06-21 | Collagenex Pharmaceuticals, Inc. | Doxycycline for the treatment of acne |
| US7704959B2 (en) * | 2006-10-03 | 2010-04-27 | Dow Pharmaceutical Sciences | Azithromycin for the treatment of nodular acne |
| CA2892739A1 (en) * | 2006-12-21 | 2008-07-03 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds for treatment of inflammatory skin disorders |
| WO2008079339A2 (en) | 2006-12-21 | 2008-07-03 | Paratek Pharmaceuticals, Inc. | Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections |
| CA2724412A1 (en) * | 2008-05-21 | 2009-11-26 | Galderma Research & Development | Maintenance therapy regimen for treating acne |
| CN102056481A (zh) * | 2008-06-05 | 2011-05-11 | 陶氏制药科学公司 | 包含低浓度的在水和水混溶性有机溶剂中的悬浮液形式的过氧苯甲酰的局部药物制剂 |
| JP2013500984A (ja) * | 2009-07-30 | 2013-01-10 | アラーガン、インコーポレイテッド | ダプソンとアダパレンの組み合わせ |
| US20140121188A1 (en) * | 2009-10-02 | 2014-05-01 | Foamix Ltd. | Compositions for the improved treatment of acne and related disorders |
| US9255068B2 (en) * | 2011-05-12 | 2016-02-09 | Warner Chilcott Company, Llc | Crystalline salts of (4S,4AS,5AR,12AS)-4-dimethylamino-3,10,12,12A-tetrahydroxy-7-[methoxy(methyl)amino)-methyl] acid amide and methods of using the same |
| IL225246A0 (en) * | 2012-03-15 | 2013-06-27 | Meir Eini | Methods for speeding up the restoration of skin normality and for treatment of impetigo |
| GB201615693D0 (en) * | 2016-09-15 | 2016-11-02 | Combinatorx Infection Ltd | Combinations |
-
2018
- 2018-07-20 CN CN201880048978.1A patent/CN111343991A/zh active Pending
- 2018-07-20 EP EP18779747.7A patent/EP3654988B1/en active Active
- 2018-07-20 BR BR112020000968-7A patent/BR112020000968A2/pt not_active Application Discontinuation
- 2018-07-20 KR KR1020207003934A patent/KR102662461B1/ko active Active
- 2018-07-20 CA CA3070663A patent/CA3070663A1/en active Pending
- 2018-07-20 MX MX2020000816A patent/MX2020000816A/es unknown
- 2018-07-20 JP JP2020524697A patent/JP2020527607A/ja active Pending
- 2018-07-20 US US16/632,121 patent/US20200222432A1/en not_active Abandoned
- 2018-07-20 AU AU2018303807A patent/AU2018303807B2/en active Active
- 2018-07-20 WO PCT/IB2018/000938 patent/WO2019016609A1/en not_active Ceased
- 2018-07-20 MA MA049641A patent/MA49641A/fr unknown
- 2018-07-20 ES ES18779747T patent/ES2962380T3/es active Active
-
2020
- 2020-01-19 IL IL272124A patent/IL272124A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2018303807B2 (en) | 2023-08-24 |
| CA3070663A1 (en) | 2019-01-24 |
| WO2019016609A1 (en) | 2019-01-24 |
| KR20200031126A (ko) | 2020-03-23 |
| EP3654988A1 (en) | 2020-05-27 |
| BR112020000968A2 (pt) | 2020-07-14 |
| ES2962380T3 (es) | 2024-03-18 |
| CN111343991A (zh) | 2020-06-26 |
| AU2018303807A1 (en) | 2020-02-13 |
| MA49641A (fr) | 2021-06-02 |
| US20200222432A1 (en) | 2020-07-16 |
| JP2020527607A (ja) | 2020-09-10 |
| MX2020000816A (es) | 2020-08-17 |
| KR102662461B1 (ko) | 2024-04-30 |
| EP3654988B1 (en) | 2023-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202006746B (en) | Methods of treatment | |
| IL253945A0 (en) | kdm1a inhibitors to treat the disease | |
| LT3631454T (lt) | Lag-3 atžvilgiu teigiamų navikų gydymas | |
| IL275496A (en) | Glycolate oxidase inhibitors to treat the disease | |
| EP3134436A4 (en) | Treatment of h-ras-driven tumors | |
| IL259996A (en) | Combinations for cancer treatment | |
| GB201804514D0 (en) | Treatment of pyroptosis | |
| LT3458052T (lt) | Vėžio kombinuotas gydymas | |
| PT3297628T (pt) | Azasetron para uso no tratamento de perda auditiva | |
| IL253854A0 (en) | A polymorph of mebendazole for the treatment and prevention of tumors | |
| IL263835A (en) | Exosome-guided treatment of cancer | |
| SI3302523T1 (sl) | Sestavek za zdravljenje tkivnih lezij | |
| GB201804515D0 (en) | Treatment of necroptosis | |
| PT3833378T (pt) | Tratamento de verrugas | |
| SG11202005850VA (en) | Methods of treatment of hypertrigl yceridemia | |
| PL3713572T3 (pl) | Leczenie tachykardii | |
| PL3630754T3 (pl) | Związki izoindolinoacetylenowe do leczenia nowotworu | |
| IL274748A (en) | Improved cancer treatment | |
| EP3110455A4 (en) | Treatment of resistant lesions | |
| IL272124A (en) | Treatment of non-inflammatory lesions | |
| IL255167A0 (en) | Compounds for the treatment of cancer | |
| GB201704287D0 (en) | Treatment of cancer | |
| GB201703857D0 (en) | Treatment of cancer | |
| GB201702565D0 (en) | Treatment of cancer | |
| GB201717977D0 (en) | Treatment of anaemia |